Development of Polymeric Nanoparticles of Garcinia mangostana Xanthones in Eudragit RL100/RS100 for Anti-Colon Cancer Drug Delivery

Figure 2

Appearance of the nanoparticle solutions. The NPs were prepared at polymer concentration of 50 mg/mL, 20% drug loading, and an aqueous phase of 0.1% tween 80. The NPs solution was photographed before freeze-drying (a) and after reconstitution of the freeze-dried NP cakes, without cryoprotectant (b), with 0.5% glucose (c), with 0.5% sucrose (d), and with 0.5% glycerol (e).